Logo image of BLE

BLACKROCK MUNI INC TR II (BLE) Stock Price, Quote, News and Overview

NYSE:BLE - New York Stock Exchange, Inc. - US09249N1019 - Currency: USD

9.96  +0.01 (+0.1%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BLE. BLE was compared to 0 industry peers in the Unkown industry. BLE may be in some trouble as it scores bad on both profitability and health. BLE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BLE was profitable.
In the past year BLE had a positive cash flow from operations.
BLE had positive earnings in 4 of the past 5 years.
In the past 5 years BLE always reported a positive cash flow from operatings.
BLE Yearly Net Income VS EBIT VS OCF VS FCFBLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA -0.32%
ROE -0.51%
ROIC 1.85%
ROA(3y)1.37%
ROA(5y)2.02%
ROE(3y)2.25%
ROE(5y)3.28%
ROIC(3y)1.92%
ROIC(5y)2.12%
BLE Yearly ROA, ROE, ROICBLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

1.3 Margins

In the last couple of years the Operating Margin of BLE has declined.
In the last couple of years the Gross Margin of BLE has declined.
Industry RankSector Rank
OM 52.2%
PM (TTM) N/A
GM 52.9%
OM growth 3Y-7.35%
OM growth 5Y-6.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.47%
GM growth 5Y-6.54%
BLE Yearly Profit, Operating, Gross MarginsBLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150

2

2. Health

2.1 Basic Checks

BLE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BLE has been increased compared to 5 years ago.
Compared to 1 year ago, BLE has an improved debt to assets ratio.
BLE Yearly Shares OutstandingBLE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BLE Yearly Total Debt VS Total AssetsBLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

BLE has an Altman-Z score of 0.80. This is a bad value and indicates that BLE is not financially healthy and even has some risk of bankruptcy.
BLE has a debt to FCF ratio of 3.15. This is a good value and a sign of high solvency as BLE would need 3.15 years to pay back of all of its debts.
BLE has a Debt/Equity ratio of 0.58. This is a neutral value indicating BLE is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.15
Altman-Z 0.8
ROIC/WACCN/A
WACCN/A
BLE Yearly LT Debt VS Equity VS FCFBLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

BLE has a Current Ratio of 0.04. This is a bad value and indicates that BLE is not financially healthy enough and could expect problems in meeting its short term obligations.
BLE has a Quick Ratio of 0.04. This is a bad value and indicates that BLE is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
BLE Yearly Current Assets VS Current LiabilitesBLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2

3. Growth

3.1 Past

The earnings per share for BLE have decreased strongly by -32.84% in the last year.
The Revenue has been growing slightly by 0.10% in the past year.
BLE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.23% yearly.
EPS 1Y (TTM)-32.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%648.5%
Revenue 1Y (TTM)0.1%
Revenue growth 3Y17.71%
Revenue growth 5Y9.23%
Sales Q2Q%-5.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLE Yearly Revenue VS EstimatesBLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.18, BLE can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of BLE to the average of the S&P500 Index (28.98), we can say BLE is valued inline with the index average.
Industry RankSector Rank
PE 30.18
Fwd PE N/A
BLE Price Earnings VS Forward Price EarningsBLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.45
EV/EBITDA N/A
BLE Per share dataBLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.87%, BLE is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.46, BLE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.87%

5.2 History

The dividend of BLE decreases each year by -7.79%.
BLE has paid a dividend for at least 10 years, which is a reliable track record.
BLE has decreased its dividend recently.
Dividend Growth(5Y)-7.79%
Div Incr Years1
Div Non Decr Years1
BLE Yearly Dividends per shareBLE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-864.41%
EPS Next 2YN/A
EPS Next 3YN/A
BLE Yearly Income VS Free CF VS DividendBLE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

BLACKROCK MUNI INC TR II

NYSE:BLE (4/29/2025, 8:04:00 PM)

9.96

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.24%
Inst Owner Change0.52%
Ins OwnersN/A
Ins Owner Change0.05%
Market Cap475.39M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield 5.87%
Yearly Dividend0.52
Dividend Growth(5Y)-7.79%
DP-864.41%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.054)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.18
Fwd PE N/A
P/S 11.49
P/FCF 4.45
P/OCF 4.45
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)0.33
EY3.31%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.24
FCFY22.47%
OCF(TTM)2.24
OCFY22.47%
SpS0.87
BVpS12.23
TBVpS12.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.32%
ROE -0.51%
ROCE 2.35%
ROIC 1.85%
ROICexc 1.86%
ROICexgc 1.86%
OM 52.2%
PM (TTM) N/A
GM 52.9%
FCFM 258.1%
ROA(3y)1.37%
ROA(5y)2.02%
ROE(3y)2.25%
ROE(5y)3.28%
ROIC(3y)1.92%
ROIC(5y)2.12%
ROICexc(3y)1.92%
ROICexc(5y)2.12%
ROICexgc(3y)1.92%
ROICexgc(5y)2.12%
ROCE(3y)2.43%
ROCE(5y)2.68%
ROICexcg growth 3Y-7.17%
ROICexcg growth 5Y-6.88%
ROICexc growth 3Y-7.17%
ROICexc growth 5Y-6.88%
OM growth 3Y-7.35%
OM growth 5Y-6.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.47%
GM growth 5Y-6.54%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.52
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 0.8
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%648.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.1%
Revenue growth 3Y17.71%
Revenue growth 5Y9.23%
Sales Q2Q%-5.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.66%
EBIT growth 3Y9.06%
EBIT growth 5Y2.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y205.14%
FCF growth 3Y63.58%
FCF growth 5Y32.65%
OCF growth 1Y205.14%
OCF growth 3Y63.58%
OCF growth 5Y32.65%